190 related articles for article (PubMed ID: 35944310)
1. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
Zhou J; Sun Y; Wang H; Wang H; Guo F; Chen X; Gong T; Jiang C; Liang P
Stem Cell Res; 2022 Oct; 64():102883. PubMed ID: 35944310
[TBL] [Abstract][Full Text] [Related]
2. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7.
Li X; Liu Y; Liu F; Wang X; Liu M; Du W; Zhao J; Wang M; Hu L; Wang C; Fu W; Dong J; Zhao X
Stem Cell Res; 2020 Mar; 43():101699. PubMed ID: 31931472
[TBL] [Abstract][Full Text] [Related]
3. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations.
Cao X; Jahng JWS; Lee C; Zha Y; Wheeler MT; Sallam K; Wu JC
Stem Cell Res; 2021 Aug; 55():102455. PubMed ID: 34352619
[TBL] [Abstract][Full Text] [Related]
4. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
5. Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene.
Guo G; Fu W; Li X; Dong J; Zhao X; Zhang Y
Stem Cell Res; 2021 May; 53():102262. PubMed ID: 33636496
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation.
Sun Y; Zhou J; Wang H; Wang H; Chen X; Gong T; Liang P; Jiang C
Stem Cell Res; 2022 Oct; 64():102898. PubMed ID: 36041398
[TBL] [Abstract][Full Text] [Related]
7. A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy.
Li X; Fu W; Guo G; Liu M; Du W; Zhao J; Liu Y; Wang L; Dong J; Zhao X
Stem Cell Res; 2021 Mar; 51():102158. PubMed ID: 33453578
[TBL] [Abstract][Full Text] [Related]
8. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7.
Dementyeva EV; Kovalenko VR; Zhiven MK; Ustyantseva EI; Kretov EI; Vyatkin YV; Zakian SM
Stem Cell Res; 2020 Jul; 46():101840. PubMed ID: 32422568
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
10. Generation of two iPSC clones (MHHi021-A and MHHi021-B) from a patient with hypertrophic cardiomyopathy with p.Arg723Gly mutation in the MYH7 gene.
Merkert S; Wunderlich S; Beier J; Franke A; Schwanke K; Göhring G; Kraft T; Francino A; Zweigerdt R; Martin U
Stem Cell Res; 2021 Apr; 52():102208. PubMed ID: 33578365
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
Ramachandra CJA; Kp MMJ; Chua J; Hernandez-Resendiz S; Liehn EA; Knöll R; Gan LM; Michaëlsson E; Jonsson MKB; Ryden-Markinhuhta K; Bhat RV; Fritsche-Danielson R; Lin YH; Sadayappan S; Tang HC; Wong P; Shim W; Hausenloy DJ
Cardiovasc Res; 2022 Jan; 118(2):517-530. PubMed ID: 33705529
[TBL] [Abstract][Full Text] [Related]
12. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control.
Fontaine V; Duboscq-Bidot L; Jouve C; Hamlin M; Curjol A; Briand V; Janiak P; Hulot JS; Pruniaux-Harnist MP; Charron P; Villard E
Stem Cell Res; 2021 Apr; 52():102245. PubMed ID: 33610018
[TBL] [Abstract][Full Text] [Related]
13. Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
Holliday M; Ross SB; Lim S; Mangala M; Hill A; Szappanos HC; Hool L; Semsarian C
Stem Cell Res; 2018 Dec; 33():269-273. PubMed ID: 30508693
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of
Loiben AM; Chien WM; Friedman CE; Chao LS; Weber G; Goldstein A; Sniadecki NJ; Murry CE; Yang KC
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902340
[TBL] [Abstract][Full Text] [Related]
15. Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs.
Montag J; Petersen B; Flögel AK; Becker E; Lucas-Hahn A; Cost GJ; Mühlfeld C; Kraft T; Niemann H; Brenner B
Sci Rep; 2018 Mar; 8(1):4786. PubMed ID: 29555974
[TBL] [Abstract][Full Text] [Related]
16. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy.
Liu L; Shenoy SP; Jahng JWS; Liu Y; Knowles JW; Zhuge Y; Wu JC
Stem Cell Res; 2021 May; 53():102279. PubMed ID: 33743363
[TBL] [Abstract][Full Text] [Related]
17. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
18. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed Functional Assessments of
Friedman CE; Fayer S; Pendyala S; Chien WM; Loiben A; Tran L; Chao LS; McKinstry A; Ahmed D; Farris SD; Stempien-Otero A; Jonlin EC; Murry CE; Starita LM; Fowler DM; Yang KC
Circ Genom Precis Med; 2024 Apr; 17(2):e004377. PubMed ID: 38362799
[TBL] [Abstract][Full Text] [Related]
20. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
